In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice

Schmeltz, 1977, Nitrogen-containing compounds in tobacco and tobacco smoke, Chem. Rev., 77, 295, 10.1021/cr60307a001 Dong, 1977, Characterization of aza-arenes in basic organic portion of suspended particulate matter, Environ. Sci. Technol., 11, 612, 10.1021/es60129a007 Engel, 1967, A superior thin-layer chromatographic procedure for the separation of aza arenes and its application to air pollution, J. Chromatogr., 31, 109, 10.1016/S0021-9673(01)86032-5 Brocco, 1973, Determination of aza-heterocyclic compounds in atmospheric dust by a combination of thin-layer and gas chromatography, J. Chromatogr., 84, 371, 10.1016/S0021-9673(01)91717-0 Lacassagne, 1964, Carcinogenic activity of some isosteric nitrogenous pentacyclic hydrocarbon carcinogens, Compt. Rend., 258, 3387 Kitahara, 1978, Synthesis and mutagenicity of 10-azabenzo[a]pyrene-4,5-oxide and other pentacyclic aza-arene oxides, Chem. Pharm. Bull. (Tokyo), 26, 1950, 10.1248/cpb.26.1950 Okuda, 1979, Identification of an ultimate mutagen of 10-azabenzo[a]pyrene: microsomal oxidation of 10-azabenzo[a]pyrene to 10-azabenzo[a]pyrene-4,5-oxide, Chem. Pharm. Bull. (Tokyo), 27, 2547, 10.1248/cpb.27.2547 Ho, 1981, Analytical and biological analysis of test materials from the synthetic fuel technologies, Mutat. Res., 85, 335, 10.1016/0165-1161(81)90224-7 Yamada, 2002, Effect of 10-aza-substitution on benzo[a]pyrene mutagenicity in both in vivo and in vitro, Mutat. Res., 521, 187, 10.1016/S1383-5718(02)00240-1 Hirao, 1976, Carcinogenic activity of quinoline on rat liver, Cancer Res., 36, 329 Shinohara, 1977, Effect of various factors on the induction of liver tumors in animals by quinoline, Jpn. J. Cancer Res., 68, 785 Suzuki, 1998, In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity, Mutat. Res., 412, 161, 10.1016/S1383-5718(97)00185-X Miyata, 1998, Antimutagenic structure modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice, Mutat. Res., 414, 165, 10.1016/S1383-5718(98)00029-1 Suzuki, 2000, Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (MutaMouse), Mutat. Res., 456, 73, 10.1016/S0027-5107(00)00128-7 Baker, 1980, Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test, Mutat. Res., 71, 43, 10.1016/0027-5107(80)90005-6 Seixas, 1982, The aza-arenes as mutagens for Salmonella typhimurium, Mutat. Res., 102, 201, 10.1016/0165-1218(82)90130-6 Kumar, 1989, Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline, Cancer Res., 49, 20 Saeki, 1997, Dual stimulatory and inhibitory effects of fluorine-substitution on mutagenicity: an extension of the enamine epoxide theory for activation of the quinoline nucleus, Biol. Pharm. Bull., 20, 646, 10.1248/bpb.20.646 M. Dong, I. Schmeltz, E. LaVoie, D. Hoffmann, Aza-arenes in the respiratory environment: analysis and assays for mutagenicity, in: P.W. Jones, R.I. Freudenthal (Eds.), Carcinogenesis: A Comprehensive Survey, vol. 3, Raven, New York, 1978, pp. 97–108. E.A. Adams, E.J. LaVoie, D. Hoffmann, Mutagenicity and metabolism of azaphenanthrenes, in: M.C. Cooke, A.J. Dennis (Eds.), Polynuclear Aromatic Hydrocarbons, Formation, Metabolism, and Measurement, Battelle Press, Columbus, OH, 1983, pp. 73–87. Summers, 1989, Lambda phage shuttle vectors for analysis of mutations in mammalian cells in culture and in transgenic mice, Mutat. Res., 220, 263, 10.1016/0165-1110(89)90030-4 Gunther, 1993, High efficiency, restriction-deficient in vitro packaging extracts for bacteriophage lambda DNA using a new E. coli lysogen, Nucleic Acids Res., 21, 3903, 10.1093/nar/21.16.3903 Gossen, 1992, Application of galactose-sensitive E. coli strains as selective hosts for LacZ-plasmids, Nucleic Acids Res., 20, 3254, 10.1093/nar/20.12.3254 Jakubczak, 1996, Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target, Proc. Natl. Acad. Sci. U.S.A., 93, 9073, 10.1073/pnas.93.17.9073 Sun, 1999, The relationship between mutant frequency and time in vivo: simple predictions for any tissue, cell type, or mutagen, Mutat. Res., 425, 179, 10.1016/S0027-5107(99)00040-8